文献速递消化、代谢与肾脏急症重症综合管理与镇静镇痛

低剂量氯胺酮与吗啡对急诊急性疼痛严重程度影响的系统评价与Meta分析

The effect of low-dose ketamine compared to morphine on the severity of acute pain in emergency situations: a systematic review and meta-analysis.
PubMed 文献 · Scand J Trauma Resusc Emerg Med · 2025-11-26
一句话结论Meta分析显示低剂量氯胺酮与吗啡在急诊急性疼痛控制上无显著差异,但氯胺酮增加头晕和涌现现象风险。

该系统评价与Meta分析纳入20项随机对照试验共2559例急诊急性疼痛患者,比较低剂量氯胺酮与吗啡的镇痛效果。结果显示,在给药后15、30、45、60、90、120分钟,氯胺酮与吗啡在数字评定量表(NRS)评分上均无显著差异;视觉模拟量表(VAS)评分在15、30、60分钟也无显著差异。两组在30、60、120分钟疼痛完全缓解率及需要补救镇痛方面无显著差异。氯胺酮未增加总体不良事件风险(RR 1.35,95%CI 0.87-2.09)和恶心风险(RR 0.99,95%CI 0.68-1.44),但显著增加头晕风险(RR 1.48,95%CI 1.08-2.03)和涌现现象风险(RR 19.06,95%CI 3.77-96.47)。亚组分析提示静脉给予氯胺酮及较低剂量(≤0.3 mg/kg)在降低急性疼痛严重程度上优于鼻内给药及较高剂量(>0.3 mg/kg)。

要点

  • 在急诊急性疼痛患者中,低剂量氯胺酮与吗啡在给药后15-120分钟各时间点的NRS评分均无显著差异。
  • 两组在30、60、120分钟疼痛完全缓解率及需要补救镇痛方面无显著差异。
  • 氯胺酮未增加总体不良事件风险(RR 1.35,95%CI 0.87-2.09)和恶心风险(RR 0.99,95%CI 0.68-1.44)。
  • 氯胺酮显著增加头晕风险(RR 1.48,95%CI 1.08-2.03)和涌现现象风险(RR 19.06,95%CI 3.77-96.47)。
  • 亚组分析提示静脉给予氯胺酮及剂量≤0.3 mg/kg在降低急性疼痛严重程度上优于鼻内给药及剂量>0.3 mg/kg。

适用人群与场景

  • 急诊环境中发生急性疼痛的患者,纳入比较低剂量氯胺酮与吗啡的随机对照试验。

研究设计与关键结果

  • 研究类型为系统评价与Meta分析,纳入20项随机对照试验,共2559例参与者。
  • 与吗啡相比,氯胺酮在给药后15分钟NRS评分无显著变化(SMD -0.23,95%CI -0.47至0.00,I²=70.92%)。
  • 与吗啡相比,氯胺酮在给药后30分钟NRS评分无显著变化(SMD -0.08,95%CI -0.23至0.08,I²=55.94%)。
  • 与吗啡相比,氯胺酮在给药后45分钟NRS评分无显著变化(SMD 0.09,95%CI -0.16至0.33,I²=69.76%)。
  • 与吗啡相比,氯胺酮在给药后60分钟NRS评分无显著变化(SMD 0.04,95%CI -0.16至0.24,I²=74.54%)。
  • 与吗啡相比,氯胺酮在给药后90分钟NRS评分无显著变化(SMD -0.09,95%CI -0.37至0.19,I²=63.86%)。
  • 与吗啡相比,氯胺酮在给药后120分钟NRS评分无显著变化(SMD -0.01,95%CI -0.18至0.16,I²=34.61%)。
  • 与吗啡相比,氯胺酮在给药后15、30、60分钟VAS评分无显著变化;两组在30、60、120分钟疼痛完全缓解率及需要补救镇痛方面无显著差异;氯胺酮未增加总体不良事件风险(RR 1.35,95%CI 0.87-2.09,I²=71.87%)和恶心风险(RR 0.99,95%CI 0.68-1.44,I²=24.94%),但显著增加头晕风险(RR 1.48,95%CI 1.08-2.03,I²=42.59%)和涌现现象风险(RR 19.06,95%CI 3.77-96.47,I²=0.00%)。

证据类型、等级与局限

  • 证据类型为系统评价与随机对照试验的Meta分析。
  • 局限性:各时间点NRS分析的异质性较高(I²最高达74.54%)。

对床旁实践的改变

  • 作者认为,氯胺酮与吗啡在控制急性疼痛严重程度上无显著差异,但氯胺酮面临更大的安全问题。
  • 亚组分析提示静脉给予氯胺酮及较低剂量(≤0.3 mg/kg)在降低急性疼痛严重程度上优于鼻内给药及较高剂量(>0.3 mg/kg)。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Recent studies have increasingly investigated the efficacy and safety of ketamine for the management of acute pain in emergency settings and compared it with standard treatments, such as morphine; however, the results remain inconsistent. This updated meta-analysis aimed to investigate the efficacy of low-dose ketamine compared to morphine on the severity of acute pain in emergency situations.

METHODS: Web of Science, the Cochrane Library, PubMed, and Scopus were systematically searched from their establishment to June 2, 2025, to identify randomized controlled trials comparing the effect of ketamine with morphine on the severity of acute pain in emergency situations. We used a random-effects model to pool data.

RESULTS: Twenty studies with 2559 participants were included. Compared to morphine, ketamine did not significantly change the numerical rating scale (NRS) score 15 min after administration (standardized mean difference (SMD) (SMD) -0.23, 95% confidence interval (CI) (-0.47, 0.00), I2 = 70.92%), 30 min after administration (SMD - 0.08, 95% CI (-0.23, 0.08), I2 = 55.94%), 45 min after administration (SMD 0.09, 95% CI (-0.16, 0.33), I2 = 69.76%), 60 min after administration (SMD 0.04, 95% CI (-0.16, 0.24), I2 = 74.54%), 90 min after administration (SMD - 0.09, 95% CI (-0.37, 0.19), I2 = 63.86%), and 120 min after administration (SMD - 0.01, 95% CI (-0.18, 0.16), I2 = 34.61%). Similarly, compared to morphine, ketamine did not significantly change the visual analogue scale (VAS) score 15 min, 30 min, and 60 min after administration. The two groups did not significantly differ in terms of complete resolution of pain at 30 min, 60 min, and 120 min after administration and the need for rescue analgesia. Ketamine did not increase the overall risk of adverse events (risk ratio (RR) 1.35, 95% CI (0.87, 2.09), I2 = 71.87%) and nausea (RR 0.99, 95% CI (0.68, 1.44), I2 = 24.94%), but significantly increased the risk of dizziness (RR 1.48, 95% CI (1.08, 2.03), I2 = 42.59%) and emergence phenomenon (RR 19.06, 95% CI (3.77, 96.47), I2 = 0.00%) compared to morphine. In subgroup analysis, intravenous ketamine and lower doses of ketamine (≤ 0.3 mg/kg) were more effective than intranasal ketamine and higher doses of ketamine (more than 0.3 mg/kg) in decreasing the severity of acute pain.

CONCLUSION: There is no significant difference in efficacy between ketamine and morphine in controlling the severity of acute pain, but ketamine faces greater safety issues compared to morphine.

来源:Scand J Trauma Resusc Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Zhang J, Ma B. The effect of low-dose ketamine compared to morphine on the severity of acute pain in emergency situations: a systematic review and meta-analysis. Scand J Trauma Resusc Emerg Med. 2025. PMID: 41299735. doi:10.1186/s13049-025-01500-5

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。